Bavarian Nordic A/S (BVNKF)
OTCMKTS · Delayed Price · Currency is USD
30.51
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.79B DKK in the quarter ending September 30, 2025, with 31.65% growth. This brings the company's revenue in the last twelve months to 6.89B, up 13.47% year-over-year. In the year 2024, Bavarian Nordic had annual revenue of 5.72B, down -19.06%.
Revenue (ttm)
6.89B DKK
Revenue Growth
+13.47%
P/S Ratio
2.20
Revenue / Employee
3.96M DKK
Employees
1,738
Market Cap
2.38B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
| Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
| Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
| Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
| Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 292.21M |
| Vaxart | 148.20M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
| Northwest Biotherapeutics | 937.00K |
| Arch Biopartners | 198.11K |
Bavarian Nordic News
- 3 days ago - Bavarian Nordic – Completion of Share Buy-Back Program - GlobeNewsWire
- 10 days ago - Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - GlobeNewsWire
- 17 days ago - Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - GlobeNewsWire
- 20 days ago - Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil - GlobeNewsWire
- 24 days ago - Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - GlobeNewsWire
- 4 weeks ago - Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - GlobeNewsWire
- 5 weeks ago - Bavarian Nordic Launches Planned Share Buy-Back Program - GlobeNewsWire
- 2 months ago - Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees - GlobeNewsWire